TR200000782T2 - Resorsinol türevleri. - Google Patents

Resorsinol türevleri.

Info

Publication number
TR200000782T2
TR200000782T2 TR2000/00782T TR200000782T TR200000782T2 TR 200000782 T2 TR200000782 T2 TR 200000782T2 TR 2000/00782 T TR2000/00782 T TR 2000/00782T TR 200000782 T TR200000782 T TR 200000782T TR 200000782 T2 TR200000782 T2 TR 200000782T2
Authority
TR
Turkey
Prior art keywords
resorcinol derivatives
resorcinol
derivatives
relates
present
Prior art date
Application number
TR2000/00782T
Other languages
English (en)
Inventor
Hu Lan
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR200000782T2 publication Critical patent/TR200000782T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut bulus, bazi resorsinol türevlerinin cilt rengini açici maddeler olarak kullanilmasiyla ilgilidir.
TR2000/00782T 1997-09-23 1998-09-21 Resorsinol türevleri. TR200000782T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5962597P 1997-09-23 1997-09-23

Publications (1)

Publication Number Publication Date
TR200000782T2 true TR200000782T2 (tr) 2000-09-21

Family

ID=22024176

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00782T TR200000782T2 (tr) 1997-09-23 1998-09-21 Resorsinol türevleri.

Country Status (45)

Country Link
US (1) US6132740A (tr)
EP (1) EP0904774B1 (tr)
JP (2) JP3591763B2 (tr)
KR (1) KR100373996B1 (tr)
CN (1) CN1176647C (tr)
AP (1) AP857A (tr)
AR (1) AR012520A1 (tr)
AT (1) ATE235220T1 (tr)
AU (1) AU735716C (tr)
BG (1) BG64524B1 (tr)
BR (1) BR9803596A (tr)
CA (1) CA2247748C (tr)
CO (1) CO5070677A1 (tr)
CZ (1) CZ297669B6 (tr)
DE (1) DE69812519T2 (tr)
DK (1) DK0904774T3 (tr)
DZ (1) DZ2614A1 (tr)
EA (1) EA003576B1 (tr)
EG (1) EG23860A (tr)
ES (1) ES2192301T3 (tr)
GT (1) GT199800150A (tr)
HR (1) HRP20000168B1 (tr)
HU (1) HUP0003743A3 (tr)
ID (1) ID24084A (tr)
IL (2) IL134598A0 (tr)
IS (1) IS2280B (tr)
MA (1) MA26548A1 (tr)
MY (1) MY117805A (tr)
NO (1) NO327177B1 (tr)
NZ (1) NZ502797A (tr)
OA (1) OA11334A (tr)
PA (1) PA8459901A1 (tr)
PE (1) PE117299A1 (tr)
PL (1) PL195192B1 (tr)
PT (1) PT904774E (tr)
SA (1) SA98190724B1 (tr)
SI (1) SI0904774T1 (tr)
SK (1) SK284983B6 (tr)
TN (1) TNSN98176A1 (tr)
TR (1) TR200000782T2 (tr)
TW (1) TW585780B (tr)
UA (1) UA57106C2 (tr)
UY (2) UY25191A1 (tr)
WO (1) WO1999015148A1 (tr)
ZA (1) ZA988669B (tr)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6414037B1 (en) * 1998-01-09 2002-07-02 Pharmascience Pharmaceutical formulations of resveratrol and methods of use thereof
FR2777186B1 (fr) * 1998-04-10 2001-03-09 Oreal Utilisation d'au moins un hydroxystilbene dans une composition raffermissante
FR2777183B1 (fr) * 1998-04-10 2001-03-02 Oreal Utilisation d'au moins un hydroxystilbene dans une composition destinee a favoriser la desquamation de la peau et composition le comprenant
HN2000000033A (es) * 1999-03-22 2001-02-02 Pfizer Prod Inc Composicion de resorcinol
IL144850A0 (en) * 1999-03-22 2002-06-30 Pfizer Resorcinol derivatives
US6878381B2 (en) * 1999-03-22 2005-04-12 Pfizer, Inc Resorcinol composition
US6828460B2 (en) * 1999-03-22 2004-12-07 Pfizer Inc. Resorcinol derivatives
US20020034772A1 (en) * 1999-06-29 2002-03-21 Orlow Seth J. Methods and compositions that affect melanogenesis
EP1134207A1 (en) * 2000-03-15 2001-09-19 Pfizer Products Inc. Process for preparing resorcinol derivatives
IT1318425B1 (it) * 2000-03-24 2003-08-25 D B P Dev Biotechnological Pro Impiego del resveratrolo per il trattamento di eczema desquamativo,acne e psoriasi.
JP4615671B2 (ja) * 2000-04-20 2011-01-19 ポーラ化成工業株式会社 炎症存在下使用用のしわ形成又は皮膚の弾力喪失の防止剤
ES2230353T3 (es) * 2000-09-11 2005-05-01 Pfizer Products Inc. Derivados de resorcinol.
WO2002024613A2 (en) * 2000-09-21 2002-03-28 Pfizer Products, Inc. Resorcinol derivatives
US6514506B1 (en) * 2001-02-14 2003-02-04 Color Access, Inc. Whitening compositions containing ascomycete derived enzyme
EP1383493A4 (en) 2001-05-02 2005-09-21 Univ New York INHIBITION OF PIGMENTATION BY INHIBITION OF FATTY ACID SYNTHASE
AU2002231759B2 (en) * 2001-05-25 2006-08-03 P&G Clairol, Inc. 1,3-dihydroxybenzene derivatives and colorants containing said compounds
US6863897B2 (en) * 2002-03-22 2005-03-08 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Stabilization of resorcinol derivatives in cosmetic compositions
US6869598B2 (en) * 2002-03-22 2005-03-22 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Stabilization of sunscreens in cosmetic compositions
EP1501928A4 (en) * 2002-05-09 2007-08-15 Univ New York MELANOGENESETEST
US7977049B2 (en) * 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US6852310B2 (en) * 2002-08-23 2005-02-08 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Skin lightening agents, compositions and methods
US20040109832A1 (en) * 2002-12-09 2004-06-10 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Di-substituted resorcinols as skin lightening agents
US7524485B2 (en) * 2002-12-12 2009-04-28 Unilever Home & Personal Care, Usa, Division Of Conopco, Inc. Skin lightening agents, compositions and methods
US6875425B2 (en) * 2002-12-12 2005-04-05 Unilever Home & Personal Care Usa Skin lightening agents, compositions and methods
DE602004026272D1 (de) * 2003-02-03 2010-05-12 Warner Lambert Co Verbesserte formulierung für hautbleichmittel
US7338979B2 (en) * 2003-02-11 2008-03-04 Warner-Lambert Company Depigmentation agents
ES2310729T3 (es) * 2003-05-20 2009-01-16 Warner-Lambert Company Llc Agentes de despigmentacion.
EP1626702A2 (en) * 2003-05-26 2006-02-22 Enprani Co., Ltd. Whitening and antioxidative cosmetic composition containing resveratrol and method for preparing the same
EP2236131A3 (en) 2003-07-01 2011-03-02 President and Fellows of Harvard College Sirt1 modulators for manipulating cell/organism lifespan/stress response
DE602004017747D1 (de) * 2003-07-08 2008-12-24 Unilever Nv Verfahren zur herstellung einer kosmetisch aktiven verbindung
JP2007527418A (ja) 2003-12-29 2007-09-27 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 肥満及びインシュリン耐性障害を治療又は防止するための組成物
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
US7300646B2 (en) * 2004-02-27 2007-11-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Skin lightening agents, compositions and methods
EP1748767B1 (en) 2004-05-28 2011-12-28 Unigen, Inc. 1-(3-methyl-2,4-dimethoxyphenyl)-3-(2',4'-dihydroxyphenyl)-propane as a potent tyrosinase inhibitor
ATE464055T1 (de) * 2004-09-14 2010-04-15 Ajinomoto Omnichem S A Topische zusammensetzungen mit phosphorylierten polyphenolen
JP5093998B2 (ja) * 2004-09-22 2012-12-12 大塚製薬株式会社 色素沈着予防又は改善剤
US20060210497A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives
US20060210498A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
WO2007077770A1 (ja) * 2005-12-26 2007-07-12 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo アルキルレゾルシノール配糖体とその製造方法並びに用途
WO2007077259A1 (en) * 2006-01-05 2007-07-12 Symrise Gmbh & Co. Kg Synergistic active preparations comprising diphenylmethane derivatives and further skin and/or hair lightening and/or senile keratosis reducing compounds
US7250158B1 (en) 2006-03-30 2007-07-31 Conopco, Inc. Skin lightening agents, compositions and methods
US7270805B1 (en) 2006-03-30 2007-09-18 Conopco, Inc. Skin lightening agents, compositions and methods
US7247294B1 (en) 2006-03-30 2007-07-24 Conopco, Inc. Skin lightening agents, compositions and methods
RU2428167C2 (ru) * 2006-06-19 2011-09-10 Курарей Ко., Лтд. Препарат для наружного нанесения на кожу, обладающий повышенной стабильностью
JP5132095B2 (ja) * 2006-07-13 2013-01-30 ポーラ化成工業株式会社 エマルション剤形の皮膚外用剤
JP4990574B2 (ja) * 2006-07-13 2012-08-01 ポーラ化成工業株式会社 新規化合物及びそれを含有する皮膚外用剤
DE102007038097A1 (de) 2007-08-13 2009-02-19 Merck Patent Gmbh Tyrosinaseinhibitoren
DE102007038098A1 (de) 2007-08-13 2009-02-19 Merck Patent Gmbh Tyrosinaseinhibitoren
WO2009064493A1 (en) * 2007-11-14 2009-05-22 New York University School Of Medicine Tricyclic compounds as melanogenesis modifiers and uses thereof
WO2009064492A1 (en) * 2007-11-14 2009-05-22 New York University School Of Medicine Quinoline compounds as melanogenesis modifiers and uses thereof
US20100040568A1 (en) * 2008-04-30 2010-02-18 Skinmedica, Inc. Steroidal compounds as melanogenesis modifiers and uses thereof
US20100010100A1 (en) * 2008-07-09 2010-01-14 Hinman Andrew W Dermatological compositions with anti-aging and skin even-toning properties
AU2009274158C1 (en) 2008-07-21 2019-09-05 Unigen, Inc. Series of skin-whitening (lightening) compounds
WO2010014361A1 (en) * 2008-07-30 2010-02-04 Edison Pharmaceuticals, Inc. Naphthoquinone compositions with anti-aging, anti- inflammatory and skin even-toning properties
FR2939136B1 (fr) * 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(heterocycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2939135B1 (fr) * 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2953834B1 (fr) 2009-12-10 2012-01-13 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
JP4825921B1 (ja) 2010-07-16 2011-11-30 株式会社 資生堂 ４−アルキルレゾルシノール誘導体及びこれを含有する皮膚外用剤
US8772252B2 (en) 2011-01-27 2014-07-08 New York University Coumarin compounds as melanogenesis modifiers and uses thereof
US8586799B2 (en) 2011-03-24 2013-11-19 Unigen, Inc. Compounds and methods for preparation of diarylpropanes
EA031098B1 (ru) 2013-03-08 2018-11-30 Юнилевер Н.В. Соединения резорцина для дерматологического применения
RU2582215C1 (ru) * 2015-01-16 2016-04-20 Александр Ливиевич Ураков Способ обесцвечивания кожи в области кровоподтека
WO2017079905A1 (en) * 2015-11-10 2017-05-18 Henkel Ag & Co. Kgaa A cosmetic composition for skin brightening
US20190307664A1 (en) 2016-06-15 2019-10-10 Conopco, Inc., D/B/A Unilever Method and cosmetic composition for enhanced transdermal delivery of alkyl substituted resorcinol
US11071701B2 (en) 2016-06-30 2021-07-27 Symrise Ag Medicament and cosmetic composition comprising resorcinol derivatives
JP7194483B2 (ja) * 2017-07-12 2022-12-22 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ 皮膚組成物ブースターオイル
IT201700104536A1 (it) 2017-09-19 2019-03-19 Cmed Aesthetics Srl Prodotti topici con sistema bifasico
GB201904744D0 (en) * 2019-04-04 2019-05-22 Univ Exeter Anti-fungal compositions
CN114206298B (zh) 2019-07-12 2024-11-15 联合利华知识产权控股有限公司 化妆品组合物中间苯二酚化合物的稳定化
WO2021081782A1 (en) * 2019-10-30 2021-05-06 Dow Global Technologies Llc Sun care compositions with hollow mesoporous silica nanospheres
JP2023523225A (ja) 2020-04-28 2023-06-02 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ Ｎ，ｎ’－ジアセチルシスチンを含有する安定化化粧品組成物
CN118388324A (zh) * 2021-12-29 2024-07-26 苏州博研医药科技有限公司 一种间苯二酚的制备方法
WO2024132395A1 (en) 2022-12-21 2024-06-27 Unilever Ip Holdings B.V. Color stabilization of formulae with an indole
WO2025140839A1 (en) 2023-12-29 2025-07-03 Unilever Ip Holdings B.V. Colour stabilization of formulae with boron nitride
WO2025225705A1 (ja) * 2024-04-25 2025-10-30 国立大学法人富山大学 メラニン分解促進剤及びメラニン産生抑制剤

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1131200A (en) * 1966-06-06 1968-10-23 Fuji Photo Film Co Ltd Process for the production of polymer images by the polymerization of vinyl compounds
GB1221325A (en) * 1967-04-06 1971-02-03 Fuji Photo Film Co Ltd Dormation of dye images from photographic images
US3933925A (en) * 1972-06-29 1976-01-20 Koppers Company, Inc. Hydrolysis of toluene diamines to produce methyl resorcinols
US4006218A (en) * 1974-07-08 1977-02-01 Johnson & Johnson Potentiated medicaments
DE2616479C2 (de) * 1976-04-14 1986-12-04 Brickl, Rolf, Dr., 7951 Warthausen Substituierte Fluoracylresorcine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel und Kosmetika
DE3127590A1 (de) * 1980-07-12 1982-08-12 Kozak, Pavel, 6600 Saarbrücken Mittel fuer die externe behandlung von hautkrakheiten
US4391827A (en) * 1980-09-08 1983-07-05 Pfizer Inc. 3-(2-Hydroxy-4-(substituted)phenyl)-cycloalkanone and cycloalkanol analgesic agents and intermediates therefor
US4526179A (en) * 1983-01-28 1985-07-02 Leonard Salesky Digital apical foramen locating apparatus
DE3604865A1 (de) * 1986-02-15 1987-08-20 Walter Dr Med Langbehn Haut-kosmetikum
JPH0651619B2 (ja) * 1988-05-09 1994-07-06 株式会社クラレ 美白剤
US4985157A (en) * 1989-05-01 1991-01-15 Mobil Oil Corporation Mixed alkoxylated alcohol-hydroquinone/resorcinol borates-antioxidants
US5059438A (en) * 1990-02-05 1991-10-22 Enzytech, Inc. Compositions and methods for inhibiting browning in foods using resorcinol derivatives
JPH054905A (ja) * 1990-10-31 1993-01-14 Pola Chem Ind Inc 化粧料
JP2801960B2 (ja) * 1990-10-31 1998-09-21 ポーラ化成工業株式会社 頭髪化粧料
JP2875374B2 (ja) * 1990-10-31 1999-03-31 ポーラ化成工業株式会社 ニキビ用化粧料
FR2679133B1 (fr) * 1991-07-17 1993-10-15 Oreal Utilisation de derives d'acides (2,5-dihydroxyphenyl)carboxyliques, leurs homologues et leurs sels dans la preparation d'une composition cosmetique ou dermatologique a action depigmentante.
EP0524439A1 (en) * 1991-07-24 1993-01-27 F.Hoffmann-La Roche & Co. Aktiengesellschaft Novel cyclohexane and tetrahydropyran derivatives and antifungal compositions containing these derivatives
CZ285937B6 (cs) * 1992-01-16 1999-12-15 Hoechst Aktiengesellschaft Arylcykloalkylové deriváty, způsob přípravy těchto derivátů a jejich použití
CA2094465A1 (en) * 1992-04-23 1993-10-24 Pierre Andre Raymond Bruneau Cycloalkane derivatives
JPH0656641A (ja) * 1992-08-05 1994-03-01 Nippon Paint Co Ltd 化粧料
US5399785A (en) * 1992-08-05 1995-03-21 Nippon Paint Co., Ltd. Tyrosinase activity inhibitor
FR2704428B1 (fr) * 1993-04-29 1995-06-09 Oreal Utilisation de dérivés de la résorcine substitués en position(s) 4, 4 et 5 ou 4 et 6 dans des compositions cosmétiques ou dermopharmaceutiques à action dépigmentante.
FR2704753B1 (fr) * 1993-05-06 1995-06-30 Oreal Utilisation de derives de la 4-thio resorcine ou 4-thio 1-3-dihydroxybenzene, dans des compositions cosmetiques ou dermopharmaceutiques a action depigmentante.
GB9418762D0 (en) * 1994-09-16 1994-11-02 Bayer Ag Use of substituted cyclopentane-DI-and-triones
JP2790986B2 (ja) * 1995-02-27 1998-08-27 住友建設株式会社 橋脚の構築方法及び施工方法

Also Published As

Publication number Publication date
BG104247A (bg) 2000-11-30
JP2004210799A (ja) 2004-07-29
CN1270509A (zh) 2000-10-18
JPH11152203A (ja) 1999-06-08
NO327177B1 (no) 2009-05-04
US6132740A (en) 2000-10-17
UY25191A1 (es) 2001-08-27
TW585780B (en) 2004-05-01
HUP0003743A2 (hu) 2001-04-28
OA11334A (en) 2003-12-10
AU8994698A (en) 1999-04-12
CZ297669B6 (cs) 2007-02-28
GT199800150A (es) 2000-03-15
JP3591763B2 (ja) 2004-11-24
PT904774E (pt) 2003-08-29
NZ502797A (en) 2002-04-26
EP0904774B1 (en) 2003-03-26
UA57106C2 (uk) 2003-06-16
CZ20001037A3 (cs) 2001-02-14
DZ2614A1 (fr) 2003-03-01
NO20001473D0 (no) 2000-03-22
SA98190724B1 (ar) 2006-05-20
BG64524B1 (bg) 2005-06-30
EA003576B1 (ru) 2003-06-26
AP857A (en) 2000-07-11
KR20010024217A (ko) 2001-03-26
BR9803596A (pt) 2000-04-25
UY25550A1 (es) 2000-02-23
EA200000251A1 (ru) 2000-08-28
HUP0003743A3 (en) 2006-02-28
IL134598A0 (en) 2001-04-30
AU735716C (en) 2007-03-29
PA8459901A1 (es) 2000-05-24
IS2280B (is) 2007-09-15
WO1999015148A1 (en) 1999-04-01
SI0904774T1 (en) 2003-10-31
IS5376A (is) 2000-02-15
MA26548A1 (fr) 2004-12-20
TNSN98176A1 (fr) 2005-03-15
DE69812519T2 (de) 2003-12-11
PL339551A1 (en) 2000-12-18
CA2247748C (en) 2002-07-02
PE117299A1 (es) 1999-11-18
NO20001473L (no) 2000-03-22
EG23860A (en) 2007-11-18
IL170545A (en) 2010-04-29
DE69812519D1 (de) 2003-04-30
CO5070677A1 (es) 2001-08-28
AP9801349A0 (en) 1998-09-30
HK1028344A1 (en) 2001-02-16
ZA988669B (en) 2000-03-22
SK3782000A3 (en) 2001-06-11
CN1176647C (zh) 2004-11-24
HRP20000168B1 (en) 2006-07-31
DK0904774T3 (da) 2003-06-16
ID24084A (id) 2000-07-06
AU735716B2 (en) 2001-07-12
AR012520A1 (es) 2000-10-18
PL195192B1 (pl) 2007-08-31
ATE235220T1 (de) 2003-04-15
HRP20000168A2 (en) 2000-08-31
SK284983B6 (sk) 2006-03-02
ES2192301T3 (es) 2003-10-01
KR100373996B1 (ko) 2003-02-26
MY117805A (en) 2004-08-30
CA2247748A1 (en) 1999-03-23
EP0904774A1 (en) 1999-03-31

Similar Documents

Publication Publication Date Title
TR200000782T2 (tr) Resorsinol türevleri.
BR0113798A (pt) Derivados de resorcinol
TR199701146T1 (tr) Nörotensin reseptörleri üzerinde etkili 1-Fenilpirazol-3-Karboksamidler.
ES2195970T3 (es) L-ribavirina y usos de la misma.
TR199902400T2 (tr) Fungusit etkinlik gösteren terkiplerin birlesimleri.
HN1997000126A (es) Derivados de indazol
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
WO2002024613A3 (en) Resorcinol derivatives
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
NO20010718L (no) Ny saltform av pantoprazol
NO954768L (no) N-alkyltiopolyaminderivater som radiobeskyttende midler
TR200102742T2 (tr) Rezorsinol türevleri
DE60207759D1 (de) Pyrimidotriazine als phosphataseinhibitoren
SE9901077D0 (sv) Novel use
TR200003389T2 (tr) 2-(2-klorofenil)-3,4-dihidro-2H-pirol türevleri.
SE9801494D0 (sv) Novel use
SE9604582D0 (sv) Novel compounds
TR200102741T2 (tr) Resorsinol bileşimi
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
ID27733A (id) Metoksiminofenilasetamida
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
YU13300A (sh) Derivati rezorcinola
SE9603726D0 (sv) Novel compounds